Skip to main content
S&P 5007,712.57+0.28%DOW52,495.88+1.02%NASDAQ26,424.82-0.02%BTC$83,097.00+1.89%ETH$2,455.36+2.50%GOLD$4,138.20-0.11%OIL$98.47+0.66%
Smart Investors Daily
SID Premium
AVITA Medical, Inc. logo

OTC · AVHHL

AVITA Medical, Inc.

Healthcare · Medical - Devices

$2.25

Up+$0.00 (+0.00%)

Updated Oct 21, 2026, 6:10 AM

SID Score

5.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
97.76M
P/E ratio
-1.8
Dividend yield
0.00%
52-week range
$0.00 – $4.01
Volume
100
Avg. volume
133

Price performance · AVHHL

AVHHL price history

1M range · 3 trading sessions · Daily adjusted prices

Prices through Oct 20, 2026

AVHHL closed at $2.25 after 3 trading sessions, up 14.80% for the selected period.

Last close
$2.25
Period change
+14.80%
Period low
$1.96
Period high
$2.25
Daily close
View OHLC price history
AVHHL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 20, 2026$2.25$2.25$2.25$2.25100
Oct 12, 2026$2.25$2.25$2.25$2.25300
Oct 1, 2026$1.96$1.96$1.96$1.96151

Latest AVHHL news

The latest Smart Investors Daily articles mentioning AVHHL.

Stock researchCompany · Overview

AVHHL research

Overview

Company profile and research snapshot.

Company profile

AVITA MED INC CDI

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
AVHHL recent ratings
DateFirmRatingTarget
Oct 12, 2026BTIGBuy—
Aug 28, 2026Lake StreetBuy—
Aug 19, 2026TD CowenBuy—
Aug 19, 2026BTIGBuy—
Aug 7, 2026BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

AVITA Medical (RCEL) Stock Sees Fair Value Lift After PermeaDerm Data And Q2 Beat

AVITA Medical’s updated valuation work now points to a fair value of $12.29, compared with the prior $11.06, which gives you a fresh reference point for where analysts see the stock’s central value today. The shift lines up with commentary that has turned more constructive after the PermeaDerm I data, recent quarterly results, and a view that current evidence and reimbursement trends support a higher fair valuation range. Read on to see what is driving this evolving narrative and how to track...

Yahoo · Sep 2, 2026

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior management will participate in the following investor conferences: Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference – Thursday, September 10, 2026 | Investor meetings with Cary Vance, President and Chief Executive Officer, and David O’Toole, Chief Financial

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By